Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Targeted Therapies in Non-small-Cell Lung Cancer.
Targeted Toxicities: Protocols for Monitoring the Adverse Events of Targeted Therapies Used in the Treatment of Non-Small Cell Lung Cancer.
Three-dimensional stereoscopic volume rendering of malignant pleural mesothelioma.
Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression.
Bevacizumab for non-small-cell lung cancer.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Bevacizumab for non-small-cell lung cancer.
Bevacizumab for non-small-cell lung cancer. N Engl J Med. 2007 Mar 29; 356(13):1373; author reply 1374-5.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Carboplatin
Carcinoma, Non-Small-Cell Lung
Humans
Lung Neoplasms
Paclitaxel
Survival Analysis
authors with profiles
Marina Chiara Garassino